Tags

Type your tag names separated by a space and hit enter

Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

Abstract

Fluoxetine, citalopram, paroxetine and venlafaxine have been widely used in the treatment of depression. However, no study has been conducted to determine the four drugs simultaneously by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

OBJECTIVE

To establish a new, rapid and sensitive HPLC-MS/ESI method for simultaneous determination and screening in human plasma of the four most commonly prescribed nontricyclic antidepressants: fluoxetine, citalopram, paroxetine and venlafaxine.

METHODS

The analytes in plasma were extracted by solid-phase-extraction column after samples had been alkalinized. The HPLC separation of the analytes was performed on a MACHEREY-NAGEL C(18) (250 mmx4.6 mm, 5 microm, Germany) column, using water (formic acid 0.6 per thousand, ammonium acetate: 30 mmol/l)-acetonitrile (35:65, v/v) as mobile phase, with a flow-rate of 0.85 ml/min. The compounds were ionized in the electrospray ionization (ESI) ion source of the mass spectrometer and were detected in the selected ion recording (SIR) mode.

RESULTS

The calibration curves were linear in the 5.0-1000.0 ng/ml range for all compounds, all of them with coefficients of determination above 0.9900. The average extraction recoveries for all the four analytes were above 73.2%. The methodology recoveries were higher than 95.0%. The limits of detection (LODs) were 0.5, 0.3, 0.3 and 0.1 ng/ml for fluoxetine, citalopram, paroxetine and venlafaxine, respectively. The intra- and inter-day variation coefficients were less than 15.0%.

CONCLUSION

The method is accurate, sensitive and simple for routine therapeutic drug monitoring (TDM) as well as toxicologic screening, and for the study of the pharmacokinetics and metabolism of the four drugs.

Authors+Show Affiliations

Clinical Pharmaceutical Research Institute, Second Xiangya Hospital, Central South University, Changsha 410011, PR China. hejuanwin@126.comNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Validation Study

Language

eng

PubMed ID

15866490

Citation

Juan, He, et al. "Simultaneous Determination of Fluoxetine, Citalopram, Paroxetine, Venlafaxine in Plasma By High Performance Liquid Chromatography-electrospray Ionization Mass Spectrometry (HPLC-MS/ESI)." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol. 820, no. 1, 2005, pp. 33-9.
Juan H, Zhiling Z, Huande L. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). J Chromatogr B Analyt Technol Biomed Life Sci. 2005;820(1):33-9.
Juan, H., Zhiling, Z., & Huande, L. (2005). Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 820(1), 33-9.
Juan H, Zhiling Z, Huande L. Simultaneous Determination of Fluoxetine, Citalopram, Paroxetine, Venlafaxine in Plasma By High Performance Liquid Chromatography-electrospray Ionization Mass Spectrometry (HPLC-MS/ESI). J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jun 5;820(1):33-9. PubMed PMID: 15866490.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). AU - Juan,He, AU - Zhiling,Zhou, AU - Huande,Li, Y1 - 2005/04/11/ PY - 2004/10/20/received PY - 2005/01/26/revised PY - 2005/03/03/accepted PY - 2005/5/4/pubmed PY - 2005/8/20/medline PY - 2005/5/4/entrez SP - 33 EP - 9 JF - Journal of chromatography. B, Analytical technologies in the biomedical and life sciences JO - J Chromatogr B Analyt Technol Biomed Life Sci VL - 820 IS - 1 N2 - UNLABELLED: Fluoxetine, citalopram, paroxetine and venlafaxine have been widely used in the treatment of depression. However, no study has been conducted to determine the four drugs simultaneously by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). OBJECTIVE: To establish a new, rapid and sensitive HPLC-MS/ESI method for simultaneous determination and screening in human plasma of the four most commonly prescribed nontricyclic antidepressants: fluoxetine, citalopram, paroxetine and venlafaxine. METHODS: The analytes in plasma were extracted by solid-phase-extraction column after samples had been alkalinized. The HPLC separation of the analytes was performed on a MACHEREY-NAGEL C(18) (250 mmx4.6 mm, 5 microm, Germany) column, using water (formic acid 0.6 per thousand, ammonium acetate: 30 mmol/l)-acetonitrile (35:65, v/v) as mobile phase, with a flow-rate of 0.85 ml/min. The compounds were ionized in the electrospray ionization (ESI) ion source of the mass spectrometer and were detected in the selected ion recording (SIR) mode. RESULTS: The calibration curves were linear in the 5.0-1000.0 ng/ml range for all compounds, all of them with coefficients of determination above 0.9900. The average extraction recoveries for all the four analytes were above 73.2%. The methodology recoveries were higher than 95.0%. The limits of detection (LODs) were 0.5, 0.3, 0.3 and 0.1 ng/ml for fluoxetine, citalopram, paroxetine and venlafaxine, respectively. The intra- and inter-day variation coefficients were less than 15.0%. CONCLUSION: The method is accurate, sensitive and simple for routine therapeutic drug monitoring (TDM) as well as toxicologic screening, and for the study of the pharmacokinetics and metabolism of the four drugs. SN - 1570-0232 UR - https://www.unboundmedicine.com/medline/citation/15866490/Simultaneous_determination_of_fluoxetine_citalopram_paroxetine_venlafaxine_in_plasma_by_high_performance_liquid_chromatography_electrospray_ionization_mass_spectrometry__HPLC_MS/ESI__ DB - PRIME DP - Unbound Medicine ER -